Log in to save to my catalogue

Subcutaneous rapid-acting insulin analogues in mild to moderate diabetic ketoacidosis: A meta-analys...

Subcutaneous rapid-acting insulin analogues in mild to moderate diabetic ketoacidosis: A meta-analys...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3119722649

Subcutaneous rapid-acting insulin analogues in mild to moderate diabetic ketoacidosis: A meta-analysis of randomized controlled trials

About this item

Full title

Subcutaneous rapid-acting insulin analogues in mild to moderate diabetic ketoacidosis: A meta-analysis of randomized controlled trials

Publisher

United States: Elsevier Inc

Journal title

Journal of diabetes and its complications, 2024-12, Vol.38 (12), p.108882, Article 108882

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Diabetic Ketoacidosis (DKA) is commonly treated with intravenous (IV) regular insulin. However, patients with less severe DKA may benefit from a subcutaneous (SC) scheme.
We systematically searched PubMed, Cochrane, and Embase for randomized controlled trials (RCTs) comparing SC rapid-acting insulin analogue (RAIAs) with IV regular insulin. Risk...

Alternative Titles

Full title

Subcutaneous rapid-acting insulin analogues in mild to moderate diabetic ketoacidosis: A meta-analysis of randomized controlled trials

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3119722649

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3119722649

Other Identifiers

ISSN

1056-8727,1873-460X

E-ISSN

1873-460X

DOI

10.1016/j.jdiacomp.2024.108882

How to access this item